Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway-Reference-Cited by-同舟云学术

Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway

Published:2021-05 Issue: Volume:148 Page:297-306
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mao Lili,Dai Jie,Cao Yabin^ORCID,Bai Xue,Sheng Xinan,Chi Zhihong,Cui Chuanliang,Kong Yan,Zhang Yanxiang,Wu Lin,Wang Xuan,Tang Bixia,Lian Bin,Yan Xieqiao,Li Siming,Zhou Li,Wei Xiaoting,Li Caili,Qi Zhonghui,Si Lu,Guo Jun

Funder

National Natural Science Foundation of China

Beijing Natural Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases;Chi;BMC Canc,2011

2. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005;Bradford;Arch Dermatol,2009

3. Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort;Si;Eur J Canc,2012

4. Safety, efficacy and biomarker analysis of toripalimab in previously treated advanced melanoma: results of the POLARIS-01 multicenter phase II trial;Tang;Clin Canc Res,2020

5. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker;Lade-Keller;J Clin Pathol,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification;BMC Medicine;2024-05-29

2. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma;Holistic Integrative Oncology;2024-05-28

3. Single-cell RNA sequencing unveils tumor heterogeneity and immune microenvironment between subungual and plantar melanoma;Scientific Reports;2024-03-25

4. Multidisciplinary approach and treatment of acral and mucosal melanoma;Frontiers in Oncology;2024-02-26

5. Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells;2024-01-05